Hinge Health Inc. and a group of investors raised $437 million in the digital physical therapy provider’s US initial public ...

Talzenna is currently approved in combination with Xtandi (enzalutamide) for individuals with castration-resistant prostate ...

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 ...